Xiangmei Zhao1, Dongying Wang2, Lijie Qin3. 1. Department of Emergency, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, People's Hospital of Henan University, No. 7 Weiwu Road, Zhengzhou, 450003, Henan, China. 2. College of Food Science and Technology, Henan University of Technology, Zhengzhou, 450001, China. 3. Department of Emergency, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, People's Hospital of Henan University, No. 7 Weiwu Road, Zhengzhou, 450003, Henan, China. qinlijie9122@sina.com.
Abstract
BACKGROUND: This meta-analysis based on prospective cohort studies aimed to evaluate the associations of lipid profiles with the risk of major adverse cardiovascular outcomes in patients with coronary heart disease (CHD). METHODS: The PubMed, Embase, and Cochrane Library electronic databases were systematically searched for prospective cohort study published through December 2019, and the pooled results were calculated using the random-effects model. RESULTS: Twenty-one studies with a total of 76,221 patients with CHD met the inclusion criteria. The per standard deviation (SD) increase in triglyceride was associated with a reduced risk of major adverse cardiovascular events (MACE). Furthermore, the per SD increase in high-density lipoprotein cholesterol (HDL-C) was associated with a reduced risk of cardiac death, whereas patients with lower HDL-C were associated with an increased risk of MACE, all-cause mortality, and cardiac death. Finally, the risk of MACE was significantly increased in patients with CHD with high lipoprotein(a) levels. CONCLUSIONS: The results of this study suggested that lipid profile variables could predict major cardiovascular outcomes and all-cause mortality in patients with CHD.
BACKGROUND: This meta-analysis based on prospective cohort studies aimed to evaluate the associations of lipid profiles with the risk of major adverse cardiovascular outcomes in patients with coronary heart disease (CHD). METHODS: The PubMed, Embase, and Cochrane Library electronic databases were systematically searched for prospective cohort study published through December 2019, and the pooled results were calculated using the random-effects model. RESULTS: Twenty-one studies with a total of 76,221 patients with CHD met the inclusion criteria. The per standard deviation (SD) increase in triglyceride was associated with a reduced risk of major adverse cardiovascular events (MACE). Furthermore, the per SD increase in high-density lipoprotein cholesterol (HDL-C) was associated with a reduced risk of cardiac death, whereas patients with lower HDL-C were associated with an increased risk of MACE, all-cause mortality, and cardiac death. Finally, the risk of MACE was significantly increased in patients with CHD with high lipoprotein(a) levels. CONCLUSIONS: The results of this study suggested that lipid profile variables could predict major cardiovascular outcomes and all-cause mortality in patients with CHD.
Authors: Max-Paul Winter; Franz Wiesbauer; Hermann Blessberger; Noemi Pavo; Patrick Sulzgruber; Kurt Huber; Johann Wojta; Klaus Distelmaier; Irene M Lang; Georg Goliasch Journal: Eur J Clin Invest Date: 2018-08-13 Impact factor: 4.686
Authors: Dena Ettehad; Connor A Emdin; Amit Kiran; Simon G Anderson; Thomas Callender; Jonathan Emberson; John Chalmers; Anthony Rodgers; Kazem Rahimi Journal: Lancet Date: 2015-12-24 Impact factor: 79.321
Authors: Dirk De Bacquer; Jean Dallongeville; Kornelia Kotseva; Marie Therese Cooney; Andrzej Pajak; Jaap W Deckers; Otto Mayer; Diego Vanuzzo; Seppo Lehto; Zlatko Fras; Erika Östor; Giovanni B Ambrosio; Guy De Backer; David Wood; Ulrich Keil; Susana Sans; Ian Graham; Kalevi Pyörälä Journal: Int J Cardiol Date: 2012-11-14 Impact factor: 4.164
Authors: Betina M R Carvalho; Laranda C Nascimento; Jessica C Nascimento; Vitória S Dos S Gonçalves; Patricia K Ziegelmann; Débora S Tavares; Adriana G Guimarães Journal: Front Pharmacol Date: 2022-02-14 Impact factor: 5.810